Psychedelics Today
Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
info_outline
PT 609 - PS 25 Morning Show - Day Three
06/20/2025
PT 609 - PS 25 Morning Show - Day Three
/episode/index/show/psychedelicstoday/id/37095475
info_outline
PT 608 - PS 25 Morning Show - Day Two
06/20/2025
PT 608 - PS 25 Morning Show - Day Two
/episode/index/show/psychedelicstoday/id/37088425
info_outline
PS 25 - Morning Show Number 1
06/19/2025
PS 25 - Morning Show Number 1
Joe Moore and Anne Philippi are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!
/episode/index/show/psychedelicstoday/id/37078950
info_outline
PT 606 - Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences
06/16/2025
PT 606 - Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson of Ambio Life Sciences
n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world’s leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale. Trevor shares his early work supporting marginalized populations in Vancouver’s Downtown Eastside, which led to the founding of Liberty Root, one of Canada’s first ibogaine clinics. Jonathan reflects on his apprenticeship in Mexican clinics, years of international advocacy with the Global Ibogaine Therapy Alliance, and drafting the first set of clinical guidelines for ibogaine detoxification. Together with paramedic and ibogaine safety protocols expert Jose Inzunza, they co-founded Ambio in Tijuana in 2021. They discuss: The unique safety standards Ambio has pioneered – including industry-wide clinical protocols and magnesium therapy to mitigate cardiac risk. Their scale: over 3,000 patients treated, with 100+ clients per month across five dedicated houses in Baja California. Ambio’s groundbreaking neuroregenerative program for Parkinson’s, MS, and traumatic brain injury – which has already drawn patients like Brett Favre and Clay Walker. How ibogaine appears to drive profound physiological change – including evidence of TBI reversal as shown in Stanford’s 2024 study on Special Forces veterans. Why ibogaine isn’t just a molecule – it opens a long-lasting “critical period” of neuroplasticity that must be supported with preparation, integration, and holistic care. The deeper story of sourcing: through his company Terragnosis, Jonathan is the only person with a legal export license for Tabernanthe iboga from Gabon, and Ambio is setting a precedent for reciprocal and ethical global supply chains. Their cautionary perspective on Texas’ $50M push toward ibogaine clinical trials – and why the traditional “one drug, one indication” model misses the complexity and promise of psychedelic healing. They also make a compelling case that Ambio is already modeling what the future of psychedelic care should look like – not a single drug in a sterile clinical setting, but a comprehensive, integrated protocol combining preparation, medical oversight, and deep integration. “Start with the end in mind,” Trevor urges – Ambio isn’t just part of the movement; it’s the blueprint for how ibogaine could be delivered worldwide. Links: Ambio Website: (Frontiers in Immunology, Feb 2025) (Nature Medicine, Jan 2024) (Frontiers in Pain Research, Aug 2023) (Journal of Psychedelic Studies, Jan 2020) Bios: Jonathan Dickinson is the Chief Executive Officer and Co-Founder of Ambio Life Sciences. One of the world’s leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field’s foundational safety guidelines and has published widely on ibogaine’s therapeutic, cultural, and ecological significance. He holds the only active export license for Tabernanthe iboga root, led the first Nagoya-compliant export from Gabon, and was initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Missoko tradition in 2022. He has co-authored peer-reviewed research on ibogaine’s potential for trauma, TBI, pain, MS, and Parkinson’s. At Ambio, he leads strategy, research, and innovation – advancing a globally scalable model of care that bridges tradition, science, and integrity. Trevor Millar is the Chief Operating Officer and Co-Founder of Ambio Life Sciences. A social entrepreneur and pioneer in ibogaine advocacy and treatment, Trevor brings over a decade of experience supporting individuals through addiction recovery, trauma healing, and post-treatment integration. His background includes co-founding the Canadian Psychedelic Association and serving as Chair of the Board for MAPS Canada. He has co-authored peer-reviewed research on ibogaine’s applications for trauma, TBI, and opioid use disorder, and has been featured in award-winning documentaries including DOSED and In Waves and War. Grounded in personal experience and guided by a philosophical approach to healing, Trevor is helping shape a new model for ethical, integrative psychedelic care on a global scale. At Ambio, Trevor leads operations, strategic partnerships, and client experience – bridging clinical care with systems design, education, and public advocacy.
/episode/index/show/psychedelicstoday/id/37033130
info_outline
PT 605 - Jeff Breau - Exploring Psychedelic Churches at Harvard Divinity School
05/27/2025
PT 605 - Jeff Breau - Exploring Psychedelic Churches at Harvard Divinity School
In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and religion, harm reduction practices, and the burgeoning psychedelic church movement. Jeff brings insights from his ethnographic research on psychedelic churches and discusses the importance of interdisciplinary collaboration for advancing understanding in this field. He also delves into the role of music in psychedelic therapy, critiques of the Mystical Experience Questionnaire (MEQ), and the potential for psychedelic chaplaincy. Tune in for an enlightening conversation on the evolving landscape of psychedelics in society and spirituality. 00:00 Introduction and Welcome 00:18 Music in Psychedelic Therapy 02:13 Cultural Context of Music in Therapy 06:08 Personal Journey into Psychedelics and Religion 08:40 Living at an Ashram and Spiritual Practices 15:52 Mystical Experience Questionnaire (MEQ) 33:01 Psychedelic Churches and Legal Challenges 46:11 The Intersection of Law and Religion 46:34 Emergence of Psychedelic Churches 48:41 The Democratization of Mystical Experiences 49:49 Technologies of Revelation 51:10 Novel Rituals and Spiritual Practices 53:49 Humor and Irreverence in Religion 56:44 Reevaluating the Term 'Cult' 01:10:11 Psychedelic Chaplaincy and Spiritual Care 01:18:44 Burning Man as a Model for Religiosity 01:22:43 The Rise of Iboga in American Christianity 01:25:56 Conclusion and Future Directions Links
/episode/index/show/psychedelicstoday/id/36736245
info_outline
PT 604 - Paul Gillis-Smith - Psychedelics, Religion & Lisa Bieberman
05/21/2025
PT 604 - Paul Gillis-Smith - Psychedelics, Religion & Lisa Bieberman
In this episode, Joe Moore sits down with from to discuss a range of fascinating topics. They begin by discussing the Harvard Divinity School and the CSWR’s mission and history. The conversation delves into the work and legacy of , a pivotal figure in the 1960s psychedelic harm reduction movement. It explores her contributions to the field through her Psychedelic Information Center. They also touch on the Quaker traditions and their intersection with LSD use, showing how spirituality and psychedelics can coalesce. Paul also talks about upcoming psychedelic and chaplaincy workshops, emphasizing the importance of spiritual care in psychedelic experiences. This episode is rich with historical insights and contemporary applications, making it a must-listen for anyone interested in psychedelics and spirituality. 00:00 Introduction and Initial Setup 00:34 Meeting at Penn's Psychedelic Conference 01:14 Postdoctoral Presentations and Indigenous Plant Medicine 03:27 Understanding CSWR and Its Evolution 07:21 Harvard's Study of Psychedelics in Society and Culture 09:11 Personal Academic Journey and Interest in Psychedelics 11:58 Role at CSWR and Ongoing Projects 18:59 Lisa Bieberman: A Pioneer in Psychedelic Education 40:53 Quaker Theology of LSD 41:58 Meeting Structure and Frequency 42:46 Profound Simple Truths 45:41 Transition to Quakerism 48:45 The New Jerusalem Prophecy 53:02 Quakerism and Its Influence 01:11:25 Clinical Chaplaincy and Psychedelics 01:18:39 Conclusion and Future Projects
/episode/index/show/psychedelicstoday/id/36662525
info_outline
PT 603 - Dr Simon Ruffell - Other Ways of Knowing
05/13/2025
PT 603 - Dr Simon Ruffell - Other Ways of Knowing
In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. Dr. Ruffell shares how his early fascination with psychiatry eventually led to a deep disillusionment with the limitations of conventional treatments—and a surprising pivot toward the Amazon. Now working at the intersection of Indigenous healing and clinical research, Ruffell describes his journey from medical school to shamanic apprenticeship. He offers insight into the Shipibo understanding of illness across three planes—spiritual, psychological, and physical—and how these ideas challenge Western frameworks. The conversation explores critical questions about the psychedelic renaissance: Are current clinical models missing the energetic and spiritual dimensions of healing? What are the risks of poorly held psychedelic sessions, and how can Indigenous knowledge guide safer practices? Dr. Ruffell advocates for deep training, cross-cultural respect, and collaborative models—such as pairing Indigenous healers with psychiatrists in clinical settings. He also discusses his work with and , organizations that partner with Indigenous communities to study the effects of ayahuasca, particularly in treating PTSD among military veterans. Early findings from their five-year study show that 84% of participants no longer meet PTSD criteria six months after retreat—a promising signal for integrative approaches. This episode offers a rare look at how science and spirituality can coexist. Whether you're a clinician, researcher, or someone seeking deeper healing, Dr. Ruffell’s story invites us to question our assumptions and expand our understanding of what true medicine can be.
/episode/index/show/psychedelicstoday/id/36552610
info_outline
PT 602 - Iboga - Talia Eisenberg, Tom Feal, Dr. Lola “Dr. O” Hoba, Kevin Franciotti
05/06/2025
PT 602 - Iboga - Talia Eisenberg, Tom Feal, Dr. Lola “Dr. O” Hoba, Kevin Franciotti
Aspen Psychedelic Symposium 2024 – Hosted by Kevin Franciotti This powerful panel explores the healing potential and complex responsibilities that come with working with Ibogaine, a potent plant-based psychedelic. Moderator Kevin Franciotti guides a heartfelt and informative conversation with Talia Eisenberg, Tom Feegel, and Dr. Lola "Dr. O" Hoba, highlighting personal transformation, medical protocols, and the importance of honoring traditional knowledge. Personal Journeys with Ibogaine Talia Eisenberg shares her recovery from opioid addiction and the founding of BEOND Ibogaine, a medical treatment center in Cancun, Mexico. Her story illustrates the plant’s unique power to interrupt addiction and awaken purpose. Tom Feegel, co-founder and CEO of BEOND, shares how his own trauma and long-term sobriety inspired a vision for a safe, respectful, and medically supervised environment for deep healing. Clinical and Cultural Wisdom Dr. Lola Hoba offers insights as a pharmacist and Yoruba herbalist, bridging traditional plant medicine knowledge with modern pharmacology. She describes how iboga works on multiple brain receptors and why it holds so much promise for treating addiction, depression, and trauma. She also cautions about its cardiac risks and calls for respectful, trained facilitation. Safety, Access, and Sustainability Panelists discuss the rigorous safety protocols at BEOND, including ICU-level care, psychiatric screening, and pre-treatment evaluations. They also explore broader questions: How can this medicine be offered responsibly? What does reciprocity mean in practice? BEOND supports Blessings of the Forest, a nonprofit in Gabon that works to stop poaching and protect Indigenous access to the sacred root. A Call for Balance and Respect This conversation highlights the importance of blending science, spirit, and social justice. From trauma healing to sustainable sourcing, each panelist emphasizes the need for compassion, caution, and connection. As laws change and access grows, the panel urges all involved to move forward with care—for the medicine, the people it serves, and the cultures that have stewarded it for generations.
/episode/index/show/psychedelicstoday/id/36416030
info_outline
PT 601 - Neuropharmacology: Psychedelics on the Brain - Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
05/02/2025
PT 601 - Neuropharmacology: Psychedelics on the Brain - Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
A panel discussion with Jim Harris, Rachel Zoeller, DPT, David W. McMillan, Ph.D., and Manesh Girn, Ph.D. Recorded live at the Aspen Psychedelic Symposium In this riveting and deeply personal conversation, moderator Jim Harris is joined by three pioneers at the intersection of neuroscience, psychedelics, and disability: Dr. Rachel Zoeller (Doctor of Physical Therapy and spinal cord injury survivor), Dr. David McMillan (Assistant Professor of Neurological Surgery at the University of Miami), and Dr. Manesh Girn (neuroscientist and postdoctoral researcher with Robin Carhart-Harris at UCSF). Together, they explore how psychedelics may do far more than treat depression or catalyze mystical experiences—they may also support healing and regeneration in the nervous system. The discussion opens with an acknowledgment that our cultural understanding of psychedelics has mostly focused on their psychological and spiritual effects. But as these experts reveal, the somatic potential of psychedelics is vast and understudied. They delve into promising areas like central and peripheral neuroplasticity, the anti-inflammatory effects of psychedelics, and how these mechanisms might play a role in healing from spinal cord injuries or paralysis. Dr. Girn breaks down the science behind psilocybin's interaction with 5-HT2A serotonin receptors, not only in the brain but also in the spinal cord. These receptors, when activated, may increase neuronal excitability and even help restore lost signaling in damaged motor pathways. He suggests that psychedelics could reopen “critical periods” for neuroplasticity—windows of opportunity for the nervous system to rewire and heal. Rachel Zoeller shares her powerful lived experience as both a physical therapist and a spinal cord injury patient. Her story brings the science to life, particularly her observation that psychedelic experiences help her reconnect to parts of her body affected by paralysis. Psychedelics, she suggests, have allowed her to rebuild mind-body communication and foster compassion toward her own physical limitations. She also underscores the need for patients to cultivate body awareness, meditation, and breathwork as essential tools for safe and effective psychedelic use. Dr. McMillan, who leads outreach at the Miami Project to Cure Paralysis, provides a clinical and safety-oriented perspective. While optimistic about the potential, he urges caution—especially with individuals who have high-level spinal cord injuries and are vulnerable to serious complications like autonomic dysreflexia. He stresses that before we can bring these treatments into clinical settings, we must carefully assess physiological risk, develop precise pharmacological protocols, and prioritize patient safety. The panel also addresses cultural and spiritual interpretations of spasticity. Drawing on both shamanic and somatic perspectives, they propose that these involuntary muscle contractions could be reinterpreted not as dysfunction, but as potential portals for healing, integration, or neurological feedback. The idea that such spasms might help the brain remap muscle groups is discussed as a provocative and hopeful reframe. The conversation wraps with a call to action: to bring together indigenous wisdom, embodied knowledge, rigorous science, and community storytelling in order to chart a new frontier in psychedelic medicine—one that does not leave the disabled community behind. As McMillan puts it, "There’s a lesson to psychedelia from paralysis.” It’s a reminder that neuropharmacology must consider not just molecules and mechanisms, but people and possibilities. Whether you're a clinician, researcher, patient, or curious explorer, this panel is a moving and illuminating look at how psychedelics could transform not only minds—but bodies. Thanks to Aspen Public Radio, Aspen Psychedelic Resource Center, Healing Advocacy Fund and Aspen Psychedelic Symposium for allowing us to share this podcast. A full agenda from the symposium can be found .
/episode/index/show/psychedelicstoday/id/36405385
info_outline
PT 600 - Sandor Iron Rope and Zach Leary
04/29/2025
PT 600 - Sandor Iron Rope and Zach Leary
In this special panel, Joe Moore of Psychedelics Today is joined by Sandor Iron Rope, Lakota spiritual leader and peyote practitioner, and Zach Leary, writer and advocate for psychedelic culture. Together, they explore the critical importance of respecting the cultural, spiritual, and ecological roots of plant medicines. Sandor shares powerful reflections on the Lakota worldview, the trauma of colonization, and the deep spiritual kinship indigenous peoples hold with medicinal plants. Zach reflects on the American counterculture's relationship with psychedelics, highlighting the need to preserve mysticism and community over commercialization. The panel dives into challenges around synthetic versus natural medicines, the risks of spiritual harm when practices are rushed or disconnected from tradition, and the urgent need for indigenous voices at the table as psychedelic policy evolves. Throughout, a theme emerges: slow down, honor kinship, and build right relationship with nature, culture, and spirit. This conversation offers a rare and necessary bridge between indigenous wisdom and the psychedelic resurgence, calling for respect, collaboration, and a return to deep roots to guide future generations. Learn more at and .
/episode/index/show/psychedelicstoday/id/36359780
info_outline
PT 599 - Sarko Diane and Rick - First to Respond
04/25/2025
PT 599 - Sarko Diane and Rick - First to Respond
This podcast comes from the Aspen Psychedelic Symposium from last summer. It features Diane Goldstein who is the executive director of Law Enforcement Action Partnership, Sarko Gergerian a police officer from Winthrop, Mass and Rick Doblin from MAPS. This panel was introduced by Zach Leary and was a highlight of our trip to Aspen's conference last year. We discuss new ways in which police should or could consider psychedelics and drugs more generally. Thanks to Aspen Public Radio and Aspen Psychedelic Symposium for allowing us to share this podcast.
/episode/index/show/psychedelicstoday/id/36302300
info_outline
PT 598 - Zach Leary - Your Extraordinary Mind
04/20/2025
PT 598 - Zach Leary - Your Extraordinary Mind
In this episode Kyle Buller and Joe Moore speak to Zach Leary about his new book "". Kyle and Joe join Zach in person for this recording. Zach has lots of hard earned wisdom and gracefully shares it with us and with his readers. We discuss MAPS PS25, Psychedelic Churches, psychedelic overuse and much more. Join us to learn more.
/episode/index/show/psychedelicstoday/id/36237455
info_outline
PT 597 - LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment
04/17/2025
PT 597 - LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment
In this episode, Joe Moore welcomes LP Giobbi, an internationally famous DJ, electronic music producer, and jazz pianist. LP shares the story behind Dead House, her project blending Grateful Dead samples with house music. What started as a tribute to her parents during pandemic live streams has become a celebrated musical movement. Joe and LP explore the deeper connection between music and psychedelics. They talk about Bicycle Day, the story of Albert Hofmann’s famous LSD bike ride, and how psychedelics can support creativity and personal growth. LP opens up about her own experiences with psychedelics, touring burnout, and how she’s learning to reconnect with her body through music and intention. The conversation also highlights LP’s work with Fem House, an educational platform that empowers women and gender-expansive individuals in music production. She explains how representation, access, and support are key to shifting the music industry. This is a warm, inspiring, candid episode about breaking barriers, finding your voice, and leading purposefully.
/episode/index/show/psychedelicstoday/id/36201565
info_outline
PT 596 - Kayse Gehret - The Modern Guide: Microdosing, Facilitation & Community
04/15/2025
PT 596 - Kayse Gehret - The Modern Guide: Microdosing, Facilitation & Community
In this episode, Kyle Buller speaks with Kayse Geheret, founder of Microdosing for Healing and instructor for Psychedelics Today’s Vital program. They explore what it means to be a modern guide in the world of psychedelics. Kayse shares how microdosing has become a key entry point for many and highlights the importance of training, community, and personal growth. They discuss how not all psychedelic work involves facilitation. Some guides support through integration, education, or community organizing. The conversation covers what makes a great guide—qualities like groundedness, empathy, curiosity, and the ability to hold space. They also talk about the growing need for psychedelic-literate professionals in all fields, not just therapy. Kayse and Kyle reflect on the importance of finding the right training—whether for coaching, integration, or peer support. With more people entering the space, education and connection are more important than ever. Whether you’re curious about microdosing, thinking of becoming a guide, or simply want to better support your community, this episode offers valuable insight. 🎧 Learn more at 🌱 Discover Vital at
/episode/index/show/psychedelicstoday/id/36146860
info_outline
PT 595 - Harry Pack - Psychedelic Surrealism
04/11/2025
PT 595 - Harry Pack - Psychedelic Surrealism
Joe Moore sits down with UK-based artist Harry Pack, whose vibrant, surreal, and often psychedelic art has captured the attention of dreamers, psychonauts, and seekers worldwide. Known for channeling the aesthetic of altered states rather than simply replicating them, Harry discusses his journey from childhood doodles to being a full-time artist working digitally in Procreate. He shares stories of deep inspiration from figures like Ott—whose album Hiraeth he recently illustrated—and how art has helped him integrate mystical experiences, recovery, and even potential alien contact. The conversation explores the therapeutic potential of art, the role of storytelling in visionary creativity, and the emergence of recurring themes in Harry’s work—most notably, the enigmatic “Purple UFO.” We also get into the importance of community, nature, and play in feeding the creative spirit, and Harry’s aspirations to build spaces for collective art-making and integration. Follow Harry on Instagram and , and explore his work at .
/episode/index/show/psychedelicstoday/id/36091430
info_outline
PT 594 - Jean-Francois Sobiecki - African Psychoactive Plants & Phytoalchemy
04/08/2025
PT 594 - Jean-Francois Sobiecki - African Psychoactive Plants & Phytoalchemy
In this episode of Psychedelics Today, Joe Moore sits down with South African ethnobotanist and healer Jean-François Sobiecki to explore the rich and largely underrecognized world of African psychoactive plants. With over two decades of fieldwork and research, Jean-François sheds light on the traditional use of these plants in healing, divination, and spiritual practices across Southern Africa. Topics covered include: Jean-François’s early inspirations and the ancestral roots of his herbal knowledge His discovery and documentation of 306 African psychoactive plant species The ritual use of Ubuwalu (dream-enhancing emetic infusions) and their role in personal transformation How vomiting, dietary restrictions, and sensory isolation are used as part of initiation processes Cross-cultural parallels between Southern African and Amazonian plant healing traditions The underexplored use of psychoactive plants to treat mental health conditions like schizophrenia and hysteria Ethical fieldwork, indigenous knowledge protection, and the dangers of overharvesting sacred plants Visions for healing and conservation gardens in Africa and the role these plants could play in global mental health Jean-François shares moving stories of his 15-year mentorship with a Northern Sotho diviner and healer, Letti Ponnya, and how she introduced him to African “plant teacher” medicines. His message is clear: Africa has a deep, sophisticated, and scientifically underappreciated tradition of psychoactive plant use that deserves recognition, respect, and further study. 📘 Get the book: 🌐 Learn more at: 📝 Related reading: ➡️
/episode/index/show/psychedelicstoday/id/36048440
info_outline
PT 593 - Vince Kadlubek - Meow Wolf & PORTAL
04/04/2025
PT 593 - Vince Kadlubek - Meow Wolf & PORTAL
In this inspiring and far-reaching conversation, Joe Moore is joined by Vince Kadlubek, the founder and Chief Visionary Officer of , the groundbreaking arts and entertainment company known for its massive, immersive art experiences. Together, they dive deep into humble DIY origins, its evolution into a multi-city creative juggernaut, and how it intertwines with psychedelic culture and expanded states of consciousness. Vince shares the story of formation in Santa Fe, the evolution from a group of passionate friends into a thousand-person company, and the power of belief, creativity, and visionary leadership. He reflects on raising funding from and major investors, navigating massive growth, and the challenge of keeping the creative spark alive in the face of institutionalization. They also discuss the upcoming , which will feature performances, talks, and immersive experiences throughout the exhibition—with appearances from Reggie Watts, Duncan Trussell, Zach Leary, and more. From the imaginative to the esoteric, Vince and Joe explore the intersection of psychedelics and art, the nature of reality and the imaginal realm, and how to build beauty and wonder into the world around us. 🌀 Topics Covered What Meow Wolf is and how it all began Growing from a DIY collective to a nationwide phenomenon Maintaining creative spirit through growth and structure Vision, belief, and the spiritual work of creating art Navigating private equity and big funding in the arts Santa Fe’s unique cultural and energetic imprint Fictional character sentience and AI in immersive worlds Art as a cultural response in times of uncertainty Psychedelics as tools for accessing the imaginal and creative realms Hosted by Portal, this one-of-a-kind immersive celebration of Bicycle Day takes over the entire Meow Wolf Denver space. Expect DJs, speakers, psychedelic storytelling, ecstatic dance, art, and surprises around every corner. Featured Guests Include: Reggie Watts Duncan Trussell LP GIOBI (Dead House) Zach Leary David Satori (Dirtwire) Frick Frack Blackjack Dennis Walker Veronica Lightning Horse Perez …and many more to be announced! 🌀 Plus: . 📍 More Info Learn more about Check out for Bicycle Day details 📣 Support the Show If you love what we do, please share this episode, leave a review, and consider supporting us in our Navigators Program.
/episode/index/show/psychedelicstoday/id/36010890
info_outline
PT 592 - Fayzan Rab - Emory University
04/01/2025
PT 592 - Fayzan Rab - Emory University
In this episode, Joe interviews Fayzan Rab, an MD candidate (when we recorded) at Emory University with a background in tech at Google and a focus on the intersection of psychedelics, spirituality, and public health. Fayzan shares Emory’s unique approach to psychedelic studies, emphasizing spiritual health and the lived religious and existential aspects of psychedelic experiences—what he and his team call “CERT.” The conversation explores Fayzan’s collaboration with health economist Elliot Marseille on economic modeling for psilocybin therapy, including their estimate that over 5 million Americans could be medically eligible. He shares insights into the policy challenges around payer systems and the importance of preparing implementation strategies before FDA approval. Fayzan also discusses his groundbreaking research on Muslim perspectives on psychedelics—revealing surprising openness, complex spiritual tensions, and a strong interest in integrating these substances into healing and faith-based frameworks. He highlights the need for inclusive infrastructure and upcoming work with clergy to deepen the conversation. Finally, they explore non-clinical psychedelic use among healthcare workers and entrepreneurs, discussing how psychedelics are being used to address burnout, identity, and life purpose. This is a powerful episode about interdisciplinary collaboration, cultural sensitivity, and the potential for psychedelics to transform not just individuals—but systems. Links - Emory University
/episode/index/show/psychedelicstoday/id/35894595
info_outline
PT 591 - Dr Hannah McLane - SoundMind
03/25/2025
PT 591 - Dr Hannah McLane - SoundMind
In this episode of Psychedelics Today, Kyle Buller is joined by Dr. Hannah McLane, founder of the SoundMind Center and SoundMind Institute. They dive deep into the evolving psychedelic landscape—touching on policy developments in New Jersey, Massachusetts, Pennsylvania, and beyond. Dr. McLane shares her experience testifying in support of psilocybin legislation and discusses the medical frameworks being explored, particularly in contrast to Oregon and Colorado’s models. The conversation also explores the essential qualities of effective psychedelic facilitators, emphasizing the importance of self-awareness, lifelong learning, and doing personal inner work. Dr. McLane offers insights into the challenges of entrepreneurship in the psychedelic space, balancing mission-driven work with sustainability, and how neurodiversity and trauma have shaped her approach. Toward the end, the conversation takes a playful and heartfelt turn, reflecting on parenting, the power of curiosity, and the need for more community-centered, human-first spaces for integration and healing. This is a rich, honest, and inspiring dialogue that bridges the personal and political, the clinical and ceremonial, and the visionary future of psychedelics.
/episode/index/show/psychedelicstoday/id/35846105
info_outline
PT 590 - Natural Medicine Alaska
03/18/2025
PT 590 - Natural Medicine Alaska
In this powerful episode of Psychedelics Today, we sit down with the team behind Natural Medicine Alaska to discuss their groundbreaking efforts to bring psychedelic reform to the state. With some of the highest rates of depression, suicide, and substance use disorders in the nation, Alaska stands at a pivotal moment in the movement for mental health transformation. Joe Moore speaks with Gina, President of Natural Medicine Alaska; David Aloff, an Alaska Native advocate; and Noria Clark, Veterans Coordinator to explore the origins of their movement, the importance of traditional healing protections, and their 2026 ballot initiative to decriminalize plant medicines and establish a regulated therapeutic model. The discussion dives into: The personal journeys that led each guest to this work How Alaska’s libertarian spirit aligns with psychedelic reform The push to make Alaska the first state to include Ibogaine clinics in legislation The urgent need for veteran and first responder access to psychedelic therapy Fundraising and grassroots efforts to get the initiative on the ballot The role of Alaska’s natural landscape in healing and psychedelic integration With national psychedelic policy at a crossroads, Alaska has the opportunity to become the North Star of this movement. Listen in to learn how you can support this critical campaign! Support Natural Medicine Alaska: 💰 Donate: 📢 Share this episode to raise awareness! 📅 Attend Arctic Visions Psychedelic Conference in August 2025: 🎧 Listen & Subscribe: Available on Spotify, Apple Podcasts, and all major platforms.
/episode/index/show/psychedelicstoday/id/35746775
info_outline
PT 589 - Erica Siegal LCSW
03/11/2025
PT 589 - Erica Siegal LCSW
Podcast Show Notes: Psychedelics, Harm Reduction & Ethical Care with Erica Siegal In this episode of Psychedelics Today, Joe Moore sits down with Erica Siegal, founder of Nest Harm Reduction and Shine Collective, for a deep conversation on psychedelic harm reduction, ethical facilitation, and the evolving psychedelic landscape. Erica shares her journey from the Grateful Dead lot scene to festival harm reduction, social work, and leading initiatives to support survivors of psychedelic-related harm. The conversation covers: Erica’s background in hospitality, social work, and psychedelic harm reduction The mission of Nest Harm Reduction in offering psychedelic therapy, integration, and community education The work of Shine Collective, a nonprofit supporting survivors of psychedelic harm and abuse The challenges of ethical facilitation, power dynamics, and the importance of clear boundaries How the psychedelic community can better address harm, accountability, and survivor support The intersection of Jewish spiritual traditions and psychedelics through Shefa This episode is a must-listen for those passionate about harm reduction, ethical psychedelic practice, and building a safer, more accountable psychedelic culture.
/episode/index/show/psychedelicstoday/id/35576465
info_outline
PT 588 - Neil Markey - Beckley Retreats
03/04/2025
PT 588 - Neil Markey - Beckley Retreats
Army Ranger to consultant to leading one of the most , detailing how meditation and psychedelic therapy helped him heal from trauma. The conversation covers: Neal’s military background and his path to psychedelics The mission and structure of Beckley Retreats, an offshoot of the Beckley Foundation How their retreats integrate meditation, preparation, and integration for long-lasting benefits The legal landscape of psilocybin in Jamaica and the Netherlands Challenges and lessons from running a psychedelic retreat business The future of psychedelics, from global access to potential federal policy shifts Whether you're curious about immersive psychedelic retreats, the intersection of mental health and psychedelics, or the evolving legal landscape, this episode is packed with insight. Learn more about here. Hear more from Neil on Psychedelics Today .
/episode/index/show/psychedelicstoday/id/35524580
info_outline
PT 587 - Paul Austin - The Third Wave
02/25/2025
PT 587 - Paul Austin - The Third Wave
In this episode, Joe Moore of Psychedelics Today sits down with Paul Austin, founder of The Third Wave, to dive deep into the evolution of microdosing and its growing role in psychedelic culture. Paul shares how his journey with microdosing LSD led him to launch The Third Wave in 2015 to make psychedelics more accessible through education. The conversation explores the latest research on microdosing, including clinical trials demonstrating its potential benefits for depression, mental clarity, and creativity. Paul and Joe discuss the nuances of different microdosing protocols, the role of psychedelics in performance optimization, and the impact of these substances on neuroplasticity. They also tackle key challenges, such as the lack of robust clinical research due to regulatory hurdles and the perceived risks associated with overuse. Beyond microdosing, they touch on the broader psychedelic landscape—regulatory shifts, emerging coaching models, and the future of psychedelic-assisted transformation. The discussion even ventures into intriguing intersections between psychedelics, AI, and the possibility of extraterrestrial intelligence. Tune in for a thought-provoking conversation on where microdosing fits into the larger psychedelic resurgence.
/episode/index/show/psychedelicstoday/id/35399090
info_outline
PT 586 - Louis Dorian - Psychedelist
02/18/2025
PT 586 - Louis Dorian - Psychedelist
In this episode of Psychedelics Today, Joe Moore sits down with Louis Dorian, the visionary behind Psychedelist, a groundbreaking global platform designed to support the emerging psychedelic movement. Described as a “cyber city” for all things psychedelic, Psychedelist connects individuals with treatment providers, educators, facilitators, legal experts, and even vetted product vendors in an effort to enhance accessibility and safety in this evolving space. Louis shares his journey into psychedelics, from early rave days to a transformative encounter with high-dose LSD and psilocybin that shaped his worldview. He opens up about the struggles of navigating trauma, loss, and the shortcomings of Western psychiatric care, leading him to develop his own trauma-processing techniques blending meditation, breathwork, and psychedelics. The conversation also dives deep into the broader implications of drug prohibition, harm reduction, and the role of skill-building in responsible psychedelic use. Whether you're a seeker, a skeptic, or a professional in the field, this episode offers a compelling exploration of the psychedelic landscape and the power of intentional community building. Resources: Visit Follow Louis Dorian on Instagram: More from Psychedelics Today: Tune in for an eye-opening discussion on the future of psychedelics, regulation, and self-exploration!
/episode/index/show/psychedelicstoday/id/35251705
info_outline
PT 585 - Neeka Levy and Zach Skiles - Healing Ukraine Trauma
02/11/2025
PT 585 - Neeka Levy and Zach Skiles - Healing Ukraine Trauma
In this episode of Psychedelics Today, Joe Moore is joined by Neeka Levy and Zach Skiles of Heal Ukraine Trauma, a nonprofit bringing psychedelic-assisted therapy to veterans and civilians affected by war. They discuss the organization’s origins, the impact of intergenerational trauma in Ukraine, and the evolving role of psychedelic treatments in a war-torn nation. Nika, a first-generation Ukrainian-American and neuroscience-trained psychiatric nurse practitioner, and Zach, a Marine veteran turned psychologist, share their journey into this work, highlighting the importance of group ketamine therapy as a scalable, culturally aligned solution. They explore Ukraine’s complex regulatory landscape, the need for rigorous research, and the challenges of working in a war zone. They also touch on the role of psychedelics in processing moral injury, the importance of including family members in healing, and how Ukraine’s collectivist culture influences therapeutic approaches. With insights on historical trauma, ethical considerations, and the potential future of MDMA and psilocybin therapy in Ukraine, this conversation sheds light on a vital, evolving effort.
/episode/index/show/psychedelicstoday/id/35239930
info_outline
PT584 – How Psychedelics Impact the Mind: Mysticism, Mental Health, and the Future of Psychedelic Research, with Josh Lipson
02/04/2025
PT584 – How Psychedelics Impact the Mind: Mysticism, Mental Health, and the Future of Psychedelic Research, with Josh Lipson
In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-world settings, the role of metaphysical perspectives in research, and why different individuals respond to psychedelics in such varied ways. Lipson shares his personal journey into psychedelic research, the challenges of interdepartmental collaboration, and the evolving landscape of modern psychedelic science. He also talks about: The importance of integration after psychedelic experience Why mystical experiences may not be the only path to healin The balance between stability and the chaos psychedelics can introduc The need for diverse perspectives and ways of knowing in psychedelic researc How psychedelics have shaped global consciousness and cultural perspectives and more! .
/episode/index/show/psychedelicstoday/id/35150540
info_outline
PT583 – How Do You Find the Right Facilitator? The Art of Matchmaking in Psychedelic Healing, with Nico & Susan Simon
01/28/2025
PT583 – How Do You Find the Right Facilitator? The Art of Matchmaking in Psychedelic Healing, with Nico & Susan Simon
In this episode, Joe interviews Nico and Susan Simon: Co-founders of JourneyŌM, a concierge service looking to address the question many people are asking: How do you find the right facilitator? Through a dedicated vetting process, JourneyŌM is adding a layer of risk reduction and accountability to this strange new world, by traveling the country and amassing a network of trusted facilitators who work with all types of medicines and modalities. By getting to know guides and seekers personally, they’re able to offer possible matches – and they usually agree on who would work best with each other. They talk about: Their process for building their network and finding the right facilitator for someone Their concept of going “beyond the bio” and getting to the heart of what drove someone toward becoming a guide Susan’s struggle with supporting Nico through his psychedelic healing, and the need for support options for spouses not sharing in the experience The importance of community and the amazing work Nico has seen in men’s groups The healing powers of movement and living as your authentic self and more! If you’re interested in JourneyŌM’s matchmaking, and take their assessment to begin the process. .
/episode/index/show/psychedelicstoday/id/35051600
info_outline
PT582 – Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule DOI and DOC, with Hamilton Morris
01/21/2025
PT582 – Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule DOI and DOC, with Hamilton Morris
In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris. After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin receptors, showing promise for chronic pain, anxiety, depression, and more. Originally recorded as a livestream in November, we felt this discussion deserved more attention, as Morris was present during the hearing and saw first-hand the damage that can come from the combination of immense overreach and outdated beliefs. He talks about: The bureaucratic mess behind so much of what the DEA doe The safety profile and research capacity of DOI and DOC and complete lack of data showing recreational us The DEA’s claim that advocates weren’t expert The fight to protect the Sonoran Desert toad and more! While we wait for the conclusion of the hearing, to hear his daily breakdowns. .
/episode/index/show/psychedelicstoday/id/34943880
info_outline
PT581 – Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust, with Jeremy Falk & Dr. David Rabin, MD, Ph.D.
01/14/2025
PT581 – Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust, with Jeremy Falk & Dr. David Rabin, MD, Ph.D.
In this episode, Joe interviews Jeremy Falk: certified instructor and training program developer for ; and Dr. David Rabin, MD, Ph.D.: board-certified psychiatrist and neuroscientist, co-founder & chief Medical Officer at Apollo Neuroscience, and advisor to the non-profit, Kama Flight Foundation. Kama Flight is a wellness modality for partners, inspired by the movements of Watsu therapy, Thai massage, 5Rhythms, tango, improv dance, and Acroyoga. At the heart of it is the dynamic between the two people engaged in the dance (the ‘base’ and the ‘voyager’), which touches on collaboration, leadership, receptivity, strength, surrender, and most importantly, trust. The communication and instant feedback shared between the partners mixed with the healing energy of the somatic movements results in moving stuck energy out of their bodies while also making them more comfortable with touch, agency, and consent – which could be extremely beneficial toward preparing for a psychedelic experience. They talk about: The four principles behind Kama Flight: permission, presence, polarity, and play The humility and humor in people trying (and failing) some of the movements, and how that is healing in itself The huge benefit in people switching between the roles of base and voyager What kind of growth they’ve seen in clients over extended periods of time The importance of making time for pleasure in our lives and more! .
/episode/index/show/psychedelicstoday/id/34852785
info_outline
PT580 – Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic Law, with Ariel Clark, JD
01/07/2025
PT580 – Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic Law, with Ariel Clark, JD
In this episode, Joe interviews Ariel Clark: Anishinaabe attorney and co-founder of the Psychedelic Bar Association, a national association of lawyers involved in the highly-regulated ecosystem of psychedelic law. She talks about ethics: How do the different societal norms of each lineage we carry interact with each other? What is the cultural framing that informs those ways of knowing, and do we align with it? Is there a code of ethics we can all agree on? As the rush to legalize psychedelics increases, Clark finds herself at a crossroads of wondering if our actions are really of service to the greater good: Can the overculture legalize psychedelics effectively, while doing less harm to Indigenous culture and the medicines themselves? She discusses: The challenges of working in psychedelic law with all of the other factors at play: How do you ethically support a client? The idea that these medicines can have agency – even the synthetic ones Shifting from a Western mind state of “what are my rights?” to an Indigenous frame of: “What are my responsibilities?” Her story of healing from debilitating back pain with psychedelics and spiritual alignment The need for public education to be at the center of future legislation attempts and more! .
/episode/index/show/psychedelicstoday/id/34759210